Avanos Medical Net Income
| AVNS Stock | USD 14.90 0.14 0.95% |
As of the 16th of February 2026, Avanos Medical shows the risk adjusted performance of 0.1608, and Mean Deviation of 1.72. Avanos Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avanos Medical coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Avanos Medical is priced correctly, providing market reflects its regular price of 14.9 per share. Given that Avanos Medical has jensen alpha of 0.3344, we suggest you to validate Avanos Medical's prevailing market performance to make sure the company can sustain itself at a future point.
Avanos Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.0785 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -352.9 M | -335.2 M | |
| Net Income Applicable To Common Shares | 45.5 M | 47.7 M | |
| Net Loss | -347.7 M | -330.3 M | |
| Net Loss | (9.80) | (9.31) | |
| Net Income Per E B T | 0.88 | 0.66 |
Avanos | Net Income | Build AI portfolio with Avanos Stock |
The evolution of Net Income for Avanos Medical provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Avanos Medical compares to historical norms and industry peers.
Latest Avanos Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Avanos Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Avanos Medical financial statement analysis. It represents the amount of money remaining after all of Avanos Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Avanos Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (392.1 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Avanos Net Income Regression Statistics
| Arithmetic Mean | (46,407,971) | |
| Coefficient Of Variation | (432.54) | |
| Mean Deviation | 157,211,253 | |
| Median | 27,100,000 | |
| Standard Deviation | 200,732,185 | |
| Sample Variance | 40293.4T | |
| Range | 580.9M | |
| R-Value | (0.65) | |
| Mean Square Error | 24943.7T | |
| R-Squared | 0.42 | |
| Significance | 0 | |
| Slope | (25,750,475) | |
| Total Sum of Squares | 644694.6T |
Avanos Net Income History
Other Fundumenentals of Avanos Medical
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Avanos Medical Net Income component correlations
Avanos Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Avanos Medical is extremely important. It helps to project a fair market value of Avanos Stock properly, considering its historical fundamentals such as Net Income. Since Avanos Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avanos Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avanos Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Avanos introduce new products? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share (10.18) | Revenue Per Share | Quarterly Revenue Growth 0.043 | Return On Assets |
Understanding Avanos Medical requires distinguishing between market price and book value, where the latter reflects Avanos's accounting equity. The concept of intrinsic value - what Avanos Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Avanos Medical's price substantially above or below its fundamental value.
Understanding that Avanos Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Avanos Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Avanos Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Avanos Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avanos Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avanos Medical.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Avanos Medical on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Avanos Medical or generate 0.0% return on investment in Avanos Medical over 90 days. Avanos Medical is related to or competes with Varex Imaging, Standard Biotools, Cytek Biosciences, Clearpoint Neuro, Pacific Biosciences, Community Health, and Bicycle Therapeutics. Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Eur... More
Avanos Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avanos Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avanos Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.77 | |||
| Information Ratio | 0.1599 | |||
| Maximum Drawdown | 9.85 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 4.68 |
Avanos Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avanos Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avanos Medical's standard deviation. In reality, there are many statistical measures that can use Avanos Medical historical prices to predict the future Avanos Medical's volatility.| Risk Adjusted Performance | 0.1608 | |||
| Jensen Alpha | 0.3344 | |||
| Total Risk Alpha | 0.2502 | |||
| Sortino Ratio | 0.2003 | |||
| Treynor Ratio | 0.3079 |
Avanos Medical February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1608 | |||
| Market Risk Adjusted Performance | 0.3179 | |||
| Mean Deviation | 1.72 | |||
| Semi Deviation | 1.48 | |||
| Downside Deviation | 1.77 | |||
| Coefficient Of Variation | 522.65 | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.94 | |||
| Information Ratio | 0.1599 | |||
| Jensen Alpha | 0.3344 | |||
| Total Risk Alpha | 0.2502 | |||
| Sortino Ratio | 0.2003 | |||
| Treynor Ratio | 0.3079 | |||
| Maximum Drawdown | 9.85 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 4.68 | |||
| Downside Variance | 3.15 | |||
| Semi Variance | 2.21 | |||
| Expected Short fall | (2.17) | |||
| Skewness | 0.3475 | |||
| Kurtosis | (0.18) |
Avanos Medical Backtested Returns
Avanos Medical appears to be not too volatile, given 3 months investment horizon. Avanos Medical secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Avanos Medical, which you can use to evaluate the volatility of the firm. Please makes use of Avanos Medical's mean deviation of 1.72, and Risk Adjusted Performance of 0.1608 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Avanos Medical holds a performance score of 17. The firm shows a Beta (market volatility) of 1.35, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Avanos Medical will likely underperform. Please check Avanos Medical's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Avanos Medical's price patterns will revert.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Avanos Medical has insignificant reverse predictability. Overlapping area represents the amount of predictability between Avanos Medical time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avanos Medical price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Avanos Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 1.31 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Avanos Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Avanos Medical reported net income of (392.1 Million). This is 214.89% lower than that of the Health Care Equipment & Supplies sector and 264.67% lower than that of the Health Care industry. The net income for all United States stocks is 168.67% higher than that of the company.
Avanos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.Avanos Medical is currently under evaluation in net income category among its peers.
Avanos Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avanos Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avanos Medical's managers, analysts, and investors.Environmental | Governance | Social |
Avanos Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Avanos Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Avanos Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Avanos Medical's value.| Shares | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 858.5 K | Tributary Capital Management, Llc | 2025-06-30 | 810.7 K | Charles Schwab Investment Management Inc | 2025-06-30 | 664.5 K | Qube Research & Technologies | 2025-06-30 | 625.4 K | Aqr Capital Management Llc | 2025-06-30 | 560.1 K | Clark Estates Inc | 2025-06-30 | 493.9 K | Northern Trust Corp | 2025-06-30 | 490.1 K | Pacer Advisors, Inc. | 2025-06-30 | 477.5 K | J. Goldman & Co Lp | 2025-06-30 | 452.4 K | Blackrock Inc | 2025-06-30 | 6.8 M | Vanguard Group Inc | 2025-06-30 | 4.5 M |
Avanos Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | 0.0158 | ||||
| Profit Margin | (0.67) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 754.84 M | ||||
| Shares Outstanding | 46.42 M | ||||
| Shares Owned By Insiders | 3.97 % | ||||
| Shares Owned By Institutions | 98.92 % | ||||
| Number Of Shares Shorted | 3.41 M | ||||
| Price To Earning | 51.23 X | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 687.8 M | ||||
| Gross Profit | 365.9 M | ||||
| EBITDA | (345.6 M) | ||||
| Net Income | (392.1 M) | ||||
| Cash And Equivalents | 106.5 M | ||||
| Cash Per Share | 2.26 X | ||||
| Total Debt | 170.2 M | ||||
| Debt To Equity | 0.24 % | ||||
| Current Ratio | 2.89 X | ||||
| Book Value Per Share | 16.76 X | ||||
| Cash Flow From Operations | 100.7 M | ||||
| Short Ratio | 5.91 X | ||||
| Earnings Per Share | (10.18) X | ||||
| Price To Earnings To Growth | 2.29 X | ||||
| Target Price | 14.0 | ||||
| Number Of Employees | 2.23 K | ||||
| Beta | 1.09 | ||||
| Market Capitalization | 691.64 M | ||||
| Total Asset | 1.15 B | ||||
| Retained Earnings | (707 M) | ||||
| Working Capital | 227.5 M | ||||
| Current Asset | 773.54 M | ||||
| Current Liabilities | 415.63 M | ||||
| Net Asset | 1.15 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.